Navigation Links
Women at Greater Risk for Hip Implant Failure, Study Finds
Date:2/18/2013

MONDAY, Feb. 18 (HealthDay News) -- Overall, the vast majority of total hip replacement surgeries are successful, but according to the results of a new study, women are at greater risk than men for implant failure after this procedure.

Researchers noted this was true even after taking other individual risk factors into account. They said their findings could help doctors better manage the anatomical differences between men and women.

"The role of sex in relationship to implant failure after total hip [replacement] is important for patient management and device innovation," the study authors wrote in the report published online Feb. 18 in JAMA Internal Medicine.

The researchers, led by Maria Inacio, of the Southern California Permanente Medical Group in San Diego, tracked more than 35,000 hip replacements that were performed at 46 different hospitals over an average follow-up period of three years. Of the patients followed, 57 percent were women who were an average age of about 66 years old.

Women more often received 28-millimeter (mm) femoral heads, while men had a higher proportion of 36-mm or larger heads. The "femoral head" is the ball-shaped top of the thigh bone that fits into the hip socket, creating the hip's "ball-and-socket" joint.

Today's artificial hips are made of a variety of materials, including metal and newer types of plastics or "polyethylene." The investigators noted that nearly 61 percent of women had metal on highly cross-linked polyethylene-bearing surfaces, compared with just under 54 percent of men. Meanwhile, 19 percent of men had metal-on-metal-bearing surfaces, compared with just under 10 percent of women.

After five years, the study showed that 97 percent of the implants survived. The researchers pointed out, however, device survival for men (97.7 percent) was deemed significantly higher than that of women (97.1 percent).

In response to the study's findings, Diana Zuckerman, from the National Research Center for Women & Families in Washington, D.C., commented in a journal news release: "Sex-specific analyses are especially important in orthopedics because of substantial anatomical sex differences."

Zuckerman added the study provides an "important first step" in understanding higher risk of hip implant failure in women, but longer follow-up is necessary to help reduce the likelihood of revision surgery.

"What is urgently needed is long-term comparative effectiveness research based on larger sample sizes, indicating which [total hip replacement] devices are less likely to fail in women and in men, with subgroup analyses based on age and other key patient traits, as well as key surgeon and hospital factors," concluded Zuckerman. "Such data would enable patients and their physicians to choose the hip devices and surgical techniques that are most likely to be successful for a longer period."

More information

The American Academy of Orthopaedic Surgeons has more information on hip implants.

-- Mary Elizabeth Dallas

SOURCE: American Medical Association, news release, Feb. 18, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Taller, Heavier Women May Face Higher Ovarian Cancer Risk
2. 62 percent of men and 37 percent of women over the age of 65 are sexually active
3. Obese White Women Shying Away From Colon Cancer Screening
4. Study: Women not getting enough exercise; at risk of developing metabolic syndrome
5. Timing pregnancy an important health concern for women
6. White Women Make Up Bulk of Assisted-Living Residents
7. Stress contributes to cognitive declines in women with breast cancer, researcher says
8. Women Less Apt Than Men to Get Recommended Daily Exercise
9. Overweight Pregnant Women at Higher Risk for Complications
10. Women With Older Partners More Often Admitted to Nursing Homes
11. Research shows efficacy of treatment model developed at Women & Infants
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Women at Greater Risk for Hip Implant Failure, Study Finds
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional women, ... towards gender equality at their inaugural Summit in New York City in June. The ... social audience of over 3 million. To watch the Mobilize Women video, click ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader ... been awarded a contract by the Center for Medicare and Medicaid Services (CMS). ... the enterprise use of Agile methodologies in a consistent and high value manner ...
(Date:10/12/2017)... San Francisco, CA (PRWEB) , ... October 12, ... ... and Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus ... sleep apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... The American ... Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium ... 8. , In honor of Morris F. Collen, a pioneer in the field of ...
(Date:10/12/2017)... PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B ... York City on October 11, 2017. , The annual award competition recognizes editorial and ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... PHILADELPHIA , Oct. 2, 2017 Halo Labs announces ... particle analysis system called the HORIZON at MIBio 2017 in ... analyzes subvisible and visible particulate matter in biopharmaceutical samples with unprecedented ... use of the novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
(Date:9/27/2017)... Sept. 27, 2017  Commended for their devotion to personalized ... Ranked as number one in the South Florida Business Journal,s ... Inc. 5000 yearly list, the national specialty pharmacy has found ... Bardisa will soon be honored by SFBJ as the ... Set to receive his award in October, Bardisa ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
Breaking Medicine Technology: